Sergio Traversa, CEO, Director at Relmada Therapeutics, holds 1.50M shares in Relmada Therapeutics (Ticker: RLMD), holds 0.00 shares in Actinium Pharmaceuticals (Ticker: ATNM). Most recently, Sergio Traversa Bought ― shares of Relmada Therapeutics on Sep 11, 2026 for an estimated value of $828.00K.
What is the percentage of profitable transactions made by Sergio Traversa?
The percentage of profitable transactions made by Sergio Traversa is 40%.
What is the average return per transaction made by Sergio Traversa?
The average return per transaction made by Sergio Traversa is 110.60%.
What stocks does Sergio Traversa hold?
Sergio Traversa holds: RLMD, ATNM stocks.
What was Sergio Traversa’s latest transaction?
Sergio Traversa latest transaction was an Informative Buy of $828.00K.
What was Sergio Traversa's most profitable transaction?
Sergio Traversa’s most profitable transaction was an Informative Buy of RLMD stock on May 20, 2025. The return on the trade was 800.00%.
What is Sergio Traversa's role in Relmada Therapeutics?
Sergio Traversa's role in Relmada Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.